Grufity logo
Grufity logo

Latest Lion Point Capital, LP Stock Portfolio

$20.91Million | No. of Holdings #35

Lion Point Capital, LP Performance

2026 Q2+16.82%
YTD+4.12%
2025+17.04%

About Lion Point Capital, LP and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Lion Point Capital, LP reported an equity portfolio of $20.9 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Lion Point Capital, LP are CUE, PRAX, MLTX. The fund has invested 8% of it's portfolio in CUE BIOPHARMA INC and 7.1% of portfolio in PRAXIS PRECISION MEDICINES I. <br><br> The fund managers got completely rid off CUE BIOPHARMA INC (CUE) stocks. Lion Point Capital, LP opened new stock positions in CUE BIOPHARMA INC (CUE).
Lion Point Capital, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$20.91Million
  as of Aug 14, 2026

Lion Point Capital, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Lion Point Capital, LP made a return of 16.82% in the last quarter. In trailing 12 months, it's portfolio return was 38.02%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
cue biopharma inc1,670,410
New stocks bought by Lion Point Capital, LP

Additions

No additions were made to existing positions by Lion Point Capital, LP

Reductions

None of the existing positions were reduced by Lion Point Capital, LP

Sold off

Ticker$ Sold
cue biopharma inc-506,436
Lion Point Capital, LP got rid off the above stocks

Sector Distribution

Lion Point Capital, LP has about 90.1% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare90.1
Others9.9

Market Cap. Distribution

Lion Point Capital, LP has about 9.6% of it's portfolio invested in the large-cap and mega-cap stocks.

  • SMALL-CAP
  • MID-CAP
  • MICRO-CAP
  • UNALLOCATED
  • LARGE-CAP
  • NANO-CAP
Category%
SMALL-CAP44.8
MID-CAP17.6
MICRO-CAP15.9
UNALLOCATED9.9
LARGE-CAP9.6
NANO-CAP2.1

Stocks belong to which Index?

About 48.2% of the stocks held by Lion Point Capital, LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others51.8
RUSSELL 200046.1
S&P 5002.1
Top 5 Winners (%)%
QURE
uniqure nv
181.7 %
CMPS
compass pathways plc
155.9 %
GHRS
gh research plc
91.2 %
biohaven ltd
75.9 %
FENC
fennec pharmaceuticals inc
74.8 %
Top 5 Winners ($)$
CMPS
compass pathways plc
0.7 M
FENC
fennec pharmaceuticals inc
0.5 M
QURE
uniqure nv
0.4 M
biohaven ltd
0.3 M
LNTH
lantheus hldgs inc
0.2 M
Top 5 Losers (%)%
JSPR
jasper therapeutics inc
-52.0 %
SRPT
sarepta therapeutics inc
-17.4 %
SPRB
spruce biosciences inc
-17.4 %
ARDX
ardelyx inc
-14.9 %
GERN
geron corp
-14.1 %
Top 5 Losers ($)$
JSPR
jasper therapeutics inc
-0.2 M
GERN
geron corp
-0.1 M
ARDX
ardelyx inc
-0.1 M
SRPT
sarepta therapeutics inc
-0.1 M
SNDX
syndax pharmaceuticals inc
-0.1 M

Lion Point Capital, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Lion Point Capital, LP

Lion Point Capital, LP has 35 stocks in it's portfolio. About 55% of the portfolio is in top 10 stocks. JSPR proved to be the most loss making stock for the portfolio. CMPS was the most profitable stock for Lion Point Capital, LP last quarter.

$20.91MTotal Value
36.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Lion Point Capital, LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
CMPS
Compass Pathways Plc

Compass Pathways Plc

CMPS
Lion Point Capital, LP's holding in Compass Pathways Plc over time
5.42%80,000
$1.13M
5.42%
unchanged 0 percentunchanged
GHRS
Gh Research Plc

Gh Research Plc

GHRS
Lion Point Capital, LP's holding in Gh Research Plc over time
1.31%10,200
$274.2K
1.31%
unchanged 0 percentunchanged
IPHA
Innate Pharma S A

Innate Pharma S A

IPHA
Lion Point Capital, LP's holding in Innate Pharma S A over time
0.71%81,151
$149.3K
0.71%
unchanged 0 percentunchanged